Article

The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

2022-06-17

Abstract excerpt

<h4>Objectives</h4> To estimate the prevalence, incidence, and longevity of antibodies against SARS-CoV-2 among primary healthcare providers (PHCPs). <h4>Design</h4> Prospective cohort study with 12 months of follow-up. <h4>Setting</h4> Primary care in Belgium <h4>Participants</h4> Any general practitioner (GP) working in primary care in Belgium and any other PHCP from the same GP practice who physically manages (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 21d47c9d-5350-5fc0-ac09-e7ab8ef3af52
DOI: 10.1101/2022.06.17.22276478

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upDOI 10.1101/2022.06.17.22276478Read

Prevalence and Incidence of Antibodies Against Sars-Cov-2 Among Primary Healthcare Providers in Belgium During One Year of the Covid-19 Epidemic: Prospective Cohort Study ProtocolSemantic proximity Read

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022Semantic proximity Read

First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, CanadaSemantic proximity Read

Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity Read

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalSemantic proximity Read

Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severitySemantic proximity Read

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysisSemantic proximity Read

Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: The ProHEpiC-19 studySemantic proximity Read

Epidemiological Parameters of SARS-CoV-2 in the UK during the 2023/2024 Winter: A Cohort StudySemantic proximity Read

Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysisSemantic proximity Read